Home Stock

Stock Research: Granules India

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Granules India

NSI:GRANULES INE101D01020
93
  • Value
    39
  • Growth
    87
  • Safety
    Safety
    75
  • Combined
    84
  • Sentiment
    86
  • 360° View
    360° View
    93
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Granules India Limited is an India-based pharmaceutical manufacturing company. It operates in pharmaceutical products, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs), and finished dosages, and owns Senn Chemicals AG, a CDMO specializing in peptide development and manufacturing. The company sells its products in global markets, including India, the United States of America, Canada, Latin America, Europe, and Asia Pacific. In the last fiscal year, the company had a market cap of $1410 million, profits of $323 million, and revenue of $524 million.

more

ANALYSIS: With an Obermatt 360° View of 93 (better than 93% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Granules India are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Granules India. The consolidated Growth Rank has a good rank of 87, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 87% of competitors in the same industry. The consolidated Safety Rank at 75 means that the company has a financing structure that is safer than 75% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 86, which means that professional investors are more optimistic about the stock than for 86% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 39, meaning that the share price of Granules India is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 61% of alternative stocks in the same industry. ...read more

more
Strongest Rank Value
Weakest Rank 360° View
Country India
Industry Pharmaceuticals
Size Medium
Website granulesindia.com
Index
Granules India stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 11-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 47 65 73
Growth
87 73 69 23
Safety
Safety
75 15 31 47
Sentiment
86 77 67 4
360° View
360° View
93 59 72 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
68 95 95 20
Opinions Change
50 72 11 50
Pro Holdings
n/a 70 67 42
Market Pulse
73 22 46 29
Sentiment
86 77 67 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 47 65 73
Growth
87 73 69 23
Safety Safety
75 15 31 47
Combined
84 33 63 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
39 60 82 78
Price vs. Earnings (P/E)
46 62 86 74
Price vs. Book (P/B)
39 53 73 67
Dividend Yield
51 12 10 36
Value
39 47 65 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
76 80 72 72
Profit Growth
69 69 32 8
Capital Growth
55 27 80 45
Stock Returns
83 79 55 27
Growth
87 73 69 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
51 30 32 36
Refinancing
84 36 46 58
Liquidity
64 32 48 55
Safety Safety
75 15 31 47

Similar Stocks

Discover high‑ranked alternatives to Granules India and broaden your portfolio horizons.

Aurobindo Pharma

NSI:AUROPHARMA
Country: India
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Gail

NSI:GAIL
Country: India
Industry: Gas Utilities
Size: X-Large
Full Stock Analysis

Apollo Tyres

NSI:APOLLOTYRE
Country: India
Industry: Tires & Rubber
Size: Large
Full Stock Analysis

Kalbe Farma

JKT:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews